65 results
Page 2 of 4
424B5
q13cchny6
16 May 23
Prospectus supplement for primary offering
5:19pm
8-K
EX-99.1
5murq6ir75d eimm0
9 May 23
Amgen and Tscan Therapeutics Announce Collaboration to Identify Novel Targets In Crohn’s Disease
9:15am
S-3
9sm46
9 Nov 22
Shelf registration
7:53am
8-K
EX-10.1
s9qdt3 3g3wr3ob
12 Sep 22
TScan Therapeutics Secures Convertible Debt Facility for up to $60 Million with K2 HealthVentures
7:51am
8-K
EX-99.1
i9f jxgogff5rp0wg
12 Sep 22
TScan Therapeutics Secures Convertible Debt Facility for up to $60 Million with K2 HealthVentures
7:51am
DEF 14A
vbk4ei68zz90ps7tqh1
21 Apr 22
Definitive proxy
8:00am
10-K
fca6 si17w071odyxw
9 Mar 22
Annual report
7:30am
8-K
EX-10.1
uspy 9o2irxya
2 Dec 21
Entry into a Material Definitive Agreement
7:31am
10-Q
f34p hi2pn
19 Aug 21
Quarterly report
7:31am
8-K
EX-3.2
fcf8nld 3k9yca4qmb
20 Jul 21
Departure of Directors or Certain Officers
4:36pm
424B4
54h9uraq1
19 Jul 21
Prospectus supplement with pricing info
7:01am